Alcami Corporation, on Nov 24, 2020 9:07:36 AM
Join Alcami on December 9
You're invited to take part in a live webinar on Wednesday, December 9 from 11:00 am to 12:00 pm EST. During this webinar, scientific experts will highlight several newer applications of ICP-MS in the pharmaceutical industry that capitalize on the technique’s versatility outside of the scope of elemental impurities.
Alcami Corporation, on Oct 26, 2020 8:58:36 AM
Join Alcami on November 18
We're launching our new environmental monitoring & cleanroom service offering with an interactive webinar on Wednesday, November 18 from 11:00 am to 12:00 pm EST. Join environmental monitoring expert, Katie Kovalevich, to learn about our newest capability.
"I've serviced over 150 cleanrooms and am thrilled to problem solve and share what I know on this critical need for so many industries," said Katie Kovalevich, Laboratory & Environmental Monitoring Sales & Marketing Manager. "If you have questions prior to the webinar, you can also schedule a meeting now." 
Alcami Corporation, on Oct 2, 2020 9:31:34 AM
CPhI Festival of Pharma is a virtual gathering launched to bring the global pharma industry together online, the Festival of Pharma fills the gap left by in-person events at a time when travel and gatherings are off the cards to let you connect with companies and clients from around the world.
Alcami Corporation, on Sep 30, 2020 11:58:11 AM
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced its acquisition of Alcami’s Germantown, Wisconsin facility in the US.
The new facility will further bolster Sterling’s US presence and will provide additional capacity for customer API development and manufacturing projects, specifically those with complex and hazardous requirements. The Germantown facility houses state-of-the-art cGMP development, scale-up and manufacturing facilities. Germantown has specialist expertise in handling technologies including plant-scale hydrogenation and cryogenic reactions.
Alcami Corporation, on Sep 29, 2020 2:27:27 PM
Join Alcami on Friday October 9
We're kicking off the opening of our new formulation and sterile fill-finish facility with a digital open house on October 9 from 1:00 to 2:00 pm EDT. Join key members of Alcami's operational and commercial leadership teams to learn about our newest facility featuring four filling lines with isolator and flexible manufacturing technology.
Alcami Corporation, on Sep 9, 2020 11:34:40 AM
Alternate methods of administering solid oral formulations are necessary to meet the needs of all patients. Geriatric, pediatric, and patients suffering from gastroesophageal reflux disease are often administered pharmaceuticals mixed with food or liquids due to difficulty swallowing tablets or capsules. For immediate release, enteric coated, modified release, or extended release dosage forms, a food study is required to evaluate whether the alternate route of administration impacts the therapeutic dose.
Alcami Corporation, on Aug 26, 2020 10:39:10 AM
Alcami, a US-based contract development and manufacturing organization, announced today that it is providing commercial manufacturing services for Trevena’s newly approved OLINVYK. OLINVYK (oliceridine) injection is an opioid approved in adults for the management of acute pain severe enough to require an intravenous opioid analgesic. Alcami has provided development and clinical support for this program for several years leading up to Trevena’s approval from the U.S. Food and Drug Administration.
Alcami Corporation, on Jul 28, 2020 10:03:04 AM
MORRISVILLE, N.C., July 28, 2020 -- Alcami, a US-based contract development and manufacturing organization (CDMO), is pleased to announce that its 56,000 square foot expansion in Research Triangle Park (RTP), reached the first milestone of operational readiness with the start of GMP laboratory testing this month. This brand-new site with state-of-the-art design and controls became part of Alcami when TriPharm Services was acquired in January 2020. 20,000 square feet will be dedicated to microbiology, formulation development, and analytical chemistry services. Specific investment has been made to offer industry-leading environmental monitoring services from this site in 2020. Operational capabilities will continue to build across the next two years with the completion of Phase 1 of the manufacturing facility in Q4 2020, which will bring the first two filling suites online and the next major milestone.
Alcami Corporation, on Jun 4, 2020 7:30:00 AM
Alcami announced today the appointment of Walter J. Kaczmarek III as Chief Executive Officer. Mr. Kaczmarek, who has over 30 years of experience in the pharmaceutical industry, will focus on advancing Alcami's next phase of strategic growth.
Mr. Kaczmarek has served in executive roles at multiple pharmaceutical companies, including as President of the Multisource Pharmaceuticals division of Mallinckrodt Pharmaceuticals, COO of Aceto Corporation, and most recently, as President and CEO of Cosette Pharmaceuticals Inc. Mr. Kaczmarek is an industry veteran with a depth of experience spanning the entire value chain from development and manufacturing to sales and marketing.
Alcami Corporation, on May 21, 2020 7:30:00 AM
WILMINGTON, NC – May 21, 2020 – Alcami, a North Carolina-based contract development and manufacturing organization (CDMO), today announced further additions to strengthen its senior leadership team. Brian Dillion has been appointed to the role of Vice President of Regulatory Affairs and Quality Assurance and Jacquelyn Uribe has been appointed to the role of Vice President of Quality Operations. “Jacque and Brian bring broad compliance expertise with a track record of success upholding the rigorous standards required by both customers and regulators in high growth environments,” commented Chief Financial Officer Eric Evans.
